SCHEMBL9004095

SCHEMBL9004095

CC(/C=C/c1ccccc1)=N\OCCCN(C)C

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCHE P06276 6/20 0.53
ACHE P22303 6/20 0.53
ALOX15 P16050 1/20 0.47
HTR2A P28223 2/20 0.46
HTR2C P28335 2/20 0.46
HTR2B P41595 1/20 0.46
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RAB9A P51151 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
GP6 Q9HCN6 1/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
LSS P48449 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004093 0.84 BCHE (0.51) BCHEACHEHTR2AHTR2CHTR2B
SCHEMBL9004126 0.82 BCHE (0.49) BCHEACHEHTR2AHTR2CHTR2B
SCHEMBL9004139 0.79 BCHE (0.46) BCHEACHEHTR2AHTR2CHTR2B
SCHEMBL4961384 0.76 TBXA2R (0.49) LSS
SCHEMBL9004133 0.76 ALOX15 (0.45) BCHEACHEALOX15LMNASMN1; SMN2
SCHEMBL9004087 0.76 SIGMAR1 (0.50) ALOX15RAB9ASIGMAR1MEN1KMT2A
SCHEMBL9004102 0.75 HTR2A (0.51) BCHEACHEALOX15HTR2AHTR2C
SCHEMBL4018802 0.74 LMNA (0.71) BCHEACHEHTR2AHTR2CLMNA
SCHEMBL4018801 0.74 LMNA (0.71) BCHEACHEHTR2AHTR2CLMNA
Hydrochloric Acid SCHEMBL9420981 0.74 HTR2A (0.62) BCHEACHEHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5486528-A ANTIULCER AGENTS, ANXIOLYTIC AGENTS EGIS GYOGYSZERGYAR RT. (HU) 1996-01-23 US disclosed
EP-0619299-A2 1-(Phenyl)-3-[omega-(amino)-alkoxyimino]-alk-1-ene derivatives, a process for preparing them as well as medicaments containing them and the use of them EGIS GYOGYSZERGYAR RT. (HU) 1994-10-12 EP disclosed